Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.22.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]    
Sales $ 635,789 $ 1,284,437
Cost of sales (726,686) (1,040,339)
Gross loss (90,897) 244,098
Operating Expenses (Income)    
Selling and marketing 320,768 482,677
General and administrative 4,814,312 6,428,625
Depreciation and amortization 170,189 196,438
Gain from insurance settlement (30,240) (165,508)
Total operating expenses 5,275,029 6,942,232
Loss from Operations (5,365,926) (6,698,134)
Other Expense (Income)    
Interest expense, net 245,174 360,413
Loss on extinguishment of debt 355,602
Gain on debt restructuring (130,421)
Gain on settlement of payables (2,100)
Gains from foreign currency translation (52,498) (101,732)
Total other expense 415,757 258,681
Net Loss (5,781,683) (6,956,815)
Net loss attributable to non-controlling interest 133,162 293,007
Series B preferred stock dividends (721,752) (721,057)
Net Loss Attributable to Common Stockholders $ (6,370,273) $ (7,384,865)
Net Loss per Common Share $ (1.47) $ (2.03)
Weighted Average Number of Common Shares Outstanding:    
Basic and Diluted 4,310,440 3,643,342